scPharmaceuticals Inc. - Margin operasi SCPH

scpharmaceuticals.com - logo grafis emiten SCPH

scPharmaceuticals Inc. (SCPH) develops innovative subcutaneous systems for heart failure therapy, attracting specialists through its scientific culture and stock options. The operating profit margin reflects efficiency dynamics, while the -133.20 metric confirms the current level. The company is actively hiring cardiologists for expansion while maintaining a stable engineering team. The outpatient treatment format reduces insurer costs and minimizes medical risks.

scPharma (SCPH): Tingkat bathi operasi saka 04.07.2022 nganti 18.10.2025

Rincian analitis lan laporan data perusahaan scPharmaceuticals, Inc. (SCPH)

- rega saham lan konsensus proyeksi valuasi:
Analisis komprehensif perusahaan:scPharmaceuticals Inc., SCPH
Produk dadi scPharmaceuticals

For scPharmaceuticals Inc. (SCPH), operating margin trends reflect the efficiency of core business process management. This metric measures the share of operating profit in total revenue before financial expenses and taxes. It is calculated by dividing the operating result by the company's total income. Growth in this metric confirms the success of diversification through the implementation of home treatment systems for heart failure. Positive momentum here signals model scalability and a reduction in patent risks.

Pesaing scPharmaceuticals Inc.

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Margin dodolan operasi AMPH (Amphastar)|PCRX - Rentabilitas dodolan operasi|Margin operasi SPRY (ars-pharma.com)|Tingkat bathi operasi TBPH|Aquestive Therapeutics, Inc. - Margin operasi|Rentabilitas dodolan operasi Tectonic Therapeutic|TNXP: Margin operasi|SXT China (SXTC) - Margin operasi|Rentabilitas operasi eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas kegiatan operasi|Rentabilitas operasi Invizyne (EXOZ)|ORMP - Rentabilitas dodolan operasi|Margin operasi ENTX (Entera Bio)|Tingkat bathi adhedhasar bathi operasi MindWalk Therapeutics|ABVC: Margin dodolan operasi|CPIX - Margin operasi|QNTM (Quantum BioPharma) - Margin dodolan operasi|Margin bathi operasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.